DelNS1-RBD4N-DAF LAIV

N/A

Report date: 2023/04/25 17:50:19

Base Information

Drug NameDelNS1-RBD4N-DAF LAIV
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Hong Kong
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Hong Kong
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A